Peer Supported Collaborative Care to Increase Engagement in Mental Health and Substance Use Disorder Care in HIV Care Settings
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 405
- 试验地点
- 1
- 主要终点
- The Number of Participants with HIV Virologic Suppression
研究概览
简要总结
This is a research study to assess the effectiveness of a peer-led collaborative care model for integrating treatment for substance use and or mental health disorders into HIV care settings.
Depending on whether or not participants enroll in this study, participants will be assigned randomly (by chance, like drawing a number from a hat) to one of two groups. In group 1, participants would receive usual clinical care. In group 2, participants would work with a peer-case manager who would help support participants to engage in substance use or mental health disorder care. Regardless of the group participants are in, participants will fill out a survey when first enrolled in the study, and then again 12 months later.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Health Services Research
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 99 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Individuals 18-99 years old
- •accessing HIV care at the Bartlett HIV clinic
- •Screened positive for a Mental health disorder or substance use disorder based on a computerized self-administered screen with Patient Health Questionnaire (PHQ-9)(score>10), General Anxiety Disorder (GAD-7) (score>10), National Institute on Drug Abuse Drug Use Screening Tool: 3 Question Quick Screen (Response of "Yes" to one or more heavy drinking days or "Yes" to use of illegal drugs or prescription drugs for non-medical reasons.
- •Does not currently have a Mental Health or Substance Use Disorder treatment provider and or not receiving any current treatment (psychotherapy or pharmacotherapy) for Mental Health or Substance Use Disorder.
- •English speaking
排除标准
- •Individuals lacking the capacity to consent
结局指标
主要结局
The Number of Participants with HIV Virologic Suppression
时间窗: Within a 3 month window of the 12 month follow-up (i.e. 3 months before or after the 12 month follow up)
This is defined as a viral load \< 200 copies/ml
次要结局
- Number of Participants with Retention in HIV Care(Within 12 months of patient entrance into the study)
- Number of Participants Who Obtain Treatment for Mental Health and Substance Use Disorder(Within 12 month of patient entrance into the study)
- Number of Participants with Change in Severity of Mental Health and Substance Use Disorder(Changes from baseline to 12 month follow up)